More like:
An Oral Zika Vaccine [Clear]

# Title Funder Funding Start End Status
1 An Oral Zika Vaccine Innovate UK
£12,166,615
 Feb. 1, 2018 April 30, 2021 Closed
2 Plant-based production of a vaccine against gonorrhoea BBSRC
£0
 Sept. 30, 2020 Sept. 29, 2024 Active
3 OxDX: Machine learning enhanced point of care diagnosis platform for infectious diseases: faster, more accessible, user intuitive, leveraging novel fluorescent labelling of enveloped viruses. Innovate UK
£287,141
 Aug. 31, 2022 Aug. 30, 2023 Active
4 OxDX: Machine learning enhanced point of care diagnosis platform for infectious diseases: faster, more accessible, user intuitive, leveraging novel fluorescent labelling of enveloped viruses. Innovate UK
£1,435,700
 Aug. 31, 2022 Aug. 31, 2023 Closed
5 Expression of recombinant SARS-CoV-2 proteins in plants BBSRC
£0
 Sept. 30, 2021 Sept. 29, 2025 Active
6 Future Vaccine Manufacturing Hub: Advancing the manufacture and deployment of cost effective vaccines EPSRC
£21,832,131
 Dec. 1, 2017 March 30, 2023 Active
7 Future Vaccine Manufacturing Hub: Advancing the manufacture and deployment of cost effective vaccines EPSRC
£62,759,750
 Dec. 1, 2017 Sept. 1, 2023 Closed
8 Vector-borne RADAR (Real-time Arbovirus Detection And Response) BBSRC
£4,619,765
 March 31, 2023 March 31, 2026 Active
9 Vaccines Without Refridgeration Innovate UK
£1,498,300
 Feb. 1, 2023 Jan. 31, 2024 Active
10 Modelling social clustering of susceptibles and its impact on measles elimination MRC
£0
 Sept. 30, 2017 May 31, 2021 Closed
11 In situ production of analgesic peptides for the treatment of joint pain UKRI
£204,031
 June 30, 2022 June 29, 2024 Active
12 Care Transformation in Respiratory Disease Innovate UK
£145,654
 May 31, 2020 March 30, 2021 Closed
13 The impact of thermally-regulated cell wall modifications on Streptococcus pneumoniae pathogenesis MRC
£2,596,485
 Jan. 2, 2023 Nov. 30, 2026 Active
14 Viral-filtering nanofibre face protection Innovate UK
£95,332
 May 31, 2020 Jan. 31, 2021 Closed
15 Dynamic stochastic block modelling for analysing recombination in HIV FIC
£38,045
 March 31, 2020 Sept. 30, 2021 Closed
16 Neptune Offshore Access System Innovate UK
£497,754
 Sept. 30, 2013 Sept. 29, 2015 Closed
17 Neptune Offshore Access System Innovate UK
£1,244,385
 Sept. 30, 2013 Sept. 30, 2015 Closed
18 Industrial Research to generate evidence for submission to NICE using a novel, real-world trial design for a technology-enabled, blended service for Cardiac Rehabilitation. Innovate UK
£391,835
 Sept. 30, 2022 March 31, 2024 Active
19 The role of resolvins - a novel class of omega 3-derived lipid mediators - in chronic pain. MRC
£0
 Sept. 30, 2018 Jan. 21, 2023 Active
20 Population-level impact and geographic spread of highly pathogenic avian influenza virus H5N1 outbreak in gannets NERC
£403,235
 Nov. 1, 2022 Oct. 31, 2023 Active
Reset